# Median Effective Dose of Lidocaine for the Prevention of Pain Caused by the Injection of Propofol Formulated With Medium-/Long-chain Triglycerides

> **NCT04008433** · NA · COMPLETED · sponsor: **Yangzhou University** · enrollment: 31 (actual)

## Conditions studied

- Lidocaine
- Injection Pain

## Interventions

- **DRUG:** Lidocaine

## Key facts

- **NCT ID:** NCT04008433
- **Lead sponsor:** Yangzhou University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-11-16
- **Primary completion:** 2018-11-16
- **Final completion:** 2019-06-13
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2020-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04008433

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04008433, "Median Effective Dose of Lidocaine for the Prevention of Pain Caused by the Injection of Propofol Formulated With Medium-/Long-chain Triglycerides". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04008433. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*